Note: The fiscal year start dates of major companies differ from the calendar year, so there may be inconsistencies between fiscal quarters, fiscal years, and the natural year. Companies may announce their performance on a quarterly or semi-annual basis.

Medtronic Announces Q4 and Fiscal Year 2024 Results Ended April 26, 2024Net sales in the fourth quarter were $8.589 billion, compared to $8.544 billion in the same period last year. Net profit attributable to the company for the quarter was $654 million, compared to $1.179 billion in the same period last year. Full-year net sales were $32.365 billion, compared to $31.227 billion in the previous fiscal year. Full-year net profit was $3.676 billion, compared to $3.758 billion in the previous fiscal year.

Johnson & Johnson Announces First Quarter 2024 Financial ResultsQuarterly sales were $21.383 billion, compared to $20.894 billion in the same period last year, representing a year-over-year increase of 2.3%. Net profit was $5.354 billion, compared to a net loss of $491 million in the same period last year. Adjusted net profit was $6.58 billion, compared to $6.34 billion in the same period last year. Of this, Innovative Pharmaceutical Business sales were $13.562 billion, an increase of 1.1% year-over-year. Medical Technology Business sales were $7.821 billion, an increase of 4.5% year-over-year.

Abbott Announces First Quarter 2024 ResultsQuarterly revenue was $9.964 billion, a year-on-year increase of 2.2%. By business segment, revenue from the medical device division was $4.453 billion, a year-on-year increase of 14.2%. Revenue from the nutrition business was $2.068 billion, a year-on-year increase of 5.1%. Diagnostic business revenue was $2.214 billion, a year-on-year decrease of 17.6%. Generic drug business sales were $1.226 billion, a year-on-year increase of 3.1%. Quarterly net profit was $1.225 billion, compared to $1.318 billion in the same period last year.

Siemens Healthineers Announces Second Quarter Results for Fiscal Year 2024, Ending March 31, 2024.Quarterly revenue was 54.35 billion euros (approximately 58.8 billion US dollars), compared to 53.46 billion euros in the same period last year. Adjusted EBIT profit for the quarter was 8.22 billion euros, compared to 7.64 billion euros in the same period last year. Quarterly net profit was 4.31 billion euros, compared to 1.08 billion euros in the same period last year.

Danaher Corporation (Danaher) announced its financial results for the first quarter of 2024.Quarterly sales were $5.796 billion, compared to $5.949 billion in the same period last year. Quarterly net profit attributable to ordinary shareholders was $1.088 billion, compared to $1.429 billion in the same period last year.

Medical device and equipment manufacturer Stryker announced its first-quarter results for 2024.Quarterly net sales were US$5.243 billion, compared to US$4.778 billion in the same period last year. Quarterly net profit was US$788 million, compared to US$592 million in the same period last year.

Fresenius Medical Care Announces First Quarter 2024 ResultsQuarterly revenue was 4.725 billion euros (approximately 5.111 billion US dollars), compared to 4.704 billion euros in the same period last year. Quarterly operating profit was 246 million euros, compared to 261 million euros in the same period last year. Quarterly net profit attributable to shareholders of the company was 70.96 million euros, compared to 86.36 million euros in the same period last year.

BD Announces First Quarter 2024 Financial Results.Total revenue for the quarter was $5.045 billion, compared to $4.821 billion in the same period last year. Net profit attributable to ordinary shareholders for the quarter was $537 million, compared to $438 million in the same period last year.

GE HealthCare Releases First Quarter 2024 Financial Results.Total quarterly revenue was $4.65 billion, compared to $4.707 billion in the same period last year. Quarterly net profit attributable to the company was $374 million, compared to $372 million in the same period last year.

Philips Announces First Quarter Results for 2024Quarterly sales reached 4.138 billion euros (approximately 4.476 billion US dollars), compared to 4.167 billion euros in the same period last year. The quarterly net loss was 998 million euros, compared to a net loss of 665 million euros in the same period last year. The adjusted EBITDA profit for the quarter was 609 million euros, compared to 575 million euros in the same period last year.

Thermo Fisher Scientific Announces First Quarter 2024 Financial ResultsQuarterly revenue was $10.345 billion, compared to $10.71 billion in the same period last year. Quarterly net profit attributable to the company was $1.328 billion, compared to $1.289 billion in the same period last year. Specifically, life sciences business revenue was $2.285 billion, laboratory products and biopharmaceutical services revenue was $5.723 billion, professional diagnostics business revenue was $1.109 billion, and analytical instruments revenue was $1.687 billion.

Boston Scientific Announces First Quarter 2024 Financial Results.Quarterly net sales were $3.856 billion, compared to $3.389 billion in the same period last year. Quarterly net profit attributable to the company's ordinary shareholders was $495 million, compared to $300 million in the same period last year.

Roche Announces Q1 2024 Financial Results.Quarterly group sales were 14.4 billion Swiss francs, compared to 15.3 billion Swiss francs in the same period last year. Pharmaceutical business sales were 10.9 billion Swiss francs, compared to 11.6 billion Swiss francs in the same period last year. Diagnostic business sales were 3.5 billion Swiss francs (approximately 3.825 billion US dollars), compared to 3.7 billion Swiss francs in the same period last year.

Baxter International Inc. announced its financial results for the first quarter of 2024.Quarterly net sales were $3.592 billion, compared to $3.513 billion in the same period last year. Quarterly net profit attributable to shareholders was $37 million, compared to $44 million in the same period last year.

Henry Schein Announces First Quarter 2024 Financial Results.Quarterly net sales were US$3.172 billion, compared to US$3.06 billion in the same period last year. Quarterly net profit attributable to the company was US$93 million, compared to US$121 million in the same period last year.

Cardinal Health Reports Third Quarter Earnings for Fiscal Year 2024 Ending March 31, 2024.Quarterly revenue was $54.9 billion, compared to $50.5 billion in the same period last year. Quarterly net profit attributable to the company was $258 million, compared to $345 million in the same period last year. Revenue from businesses such as medical products was $3.113 billion, compared to $2.989 billion in the same period last year.

Owens & Minor Reports First Quarter 2024 Financial Results. Net revenue for the quarter was $2.613 billion, compared to $2.523 billion in the same period last year. The company reported a net loss of $21.89 million for the quarter, compared to a net loss of $24.42 million in the same period last year.

3M Company Announces First Quarter 2024 Results.Quarterly net sales were $8.003 billion, compared to $8.031 billion in the same period last year. Quarterly net profit attributable to the company was $928 million, compared to $976 million in the same period last year. By business segment, net sales from Safety and Industrial businesses were $2.732 billion, Transportation and Electronics businesses were $2.104 billion, and Consumer businesses were $1.14 billion. Health Care business net sales were $2.017 billion, compared to $2.01 billion in the same period last year; operating profit was $354 million, compared to $360 million in the same period last year.

Zimmer Biomet Holdings Inc. Announces First Quarter 2024 Financial Results.Quarterly net sales were $1.89 billion, compared to $1.83 billion in the same period last year. Quarterly net profit attributable to the company was $172 million, compared to $233 million in the same period last year.

Fujifilm Holdings Announces Financial Results for the Fiscal Year 2023 Ended March 31, 2024.Group Sales Revenue Increased by 3.6% Year-on-Year, Reaching 2,960.9 Billion Yen. Operating Profit Reached 276.7 Billion Yen, a Year-on-Year Increase of 1.3%. Net Profit Attributable to FUJIFILM Holdings Increased by 11.0% Year-on-Year, Reaching 243.5 Billion Yen. By Business Segment, Healthcare Sales Revenue Was 975.1 Billion Yen (Approximately 6.21 Billion USD), with an Operating Profit of 97.4 Billion Yen. High-Performance Materials Sales Revenue Was 690 Billion Yen, with an Operating Profit of 42.9 Billion Yen. Imaging Sales Revenue Reached 469.7 Billion Yen, with an Operating Profit of 101.9 Billion Yen. Total Sales of Business Innovation Were 826.1 Billion Yen, with an Operating Profit of 70.8 Billion Yen.

Olympus (OLYMPUS) Releases Financial Results for the Fiscal Year Ended March 31, 2024Revenue for the fiscal year was 936.2 billion yen (approximately 5.962 billion USD), compared to 881.9 billion yen the previous year, representing a year-on-year increase of 6.2%. Operating profit for the fiscal year was 43.6 billion yen, compared to 186.6 billion yen the previous year. Net profit attributable to owners of the parent company for the fiscal year was 242.6 billion yen, compared to 143.4 billion yen the previous year.

Terumo Releases Financial Results for the Fiscal Year Ended March 31, 2024.Revenue for the fiscal year reached 921.9 billion yen (approximately 5.871 billion USD), compared to 820.2 billion yen in the previous year, representing a 12.4% increase. Operating profit for the fiscal year was 140.1 billion yen, up from 117.3 billion yen the previous year. Net profit attributable to owners of the parent company for the fiscal year amounted to 106.4 billion yen, compared to 89.3 billion yen in the prior year.

Mindray Medical Discloses Q1 2024 Earnings Report.Revenue in the first quarter reached 9.373 billion yuan (approximately 1.294 billion US dollars), representing a year-on-year increase of 12.06%; net profit attributable to shareholders of the listed company was 3.16 billion yuan, increasing by 22.90% compared to the same period last year. R&D investment in the first quarter amounted to 1.03 billion yuan, accounting for 10.99% of total revenue.

Canon Group Releases Q1 2024 Financial Report.Quarterly group revenue was 988.519 billion yen, compared to 971.125 billion yen in the same period last year, representing a year-on-year increase of 1.8%. Quarterly operating profit was 80.083 billion yen, compared to 84.475 billion yen in the same period last year. Quarterly net profit attributable to the company was 59.949 billion yen, compared to 56.41 billion yen in the same period last year. Among these figures, printing business revenue increased by 4.0% compared to the same period last year, reaching 580.3 billion yen. Medical business revenue grew by 2.4% compared to the same period last year, reaching 134.2 billion yen (approximately 8.55 billion US dollars). Imaging business revenue decreased by 8.8% year-on-year, amounting to 175.5 billion yen. Industrial business revenue increased by 10.4% year-on-year, totaling 68.5 billion yen.

Ophthalmology

EssilorLuxottica Reports First Quarter 2024 ResultsTotal quarterly revenue was 6.335 billion euros, compared to 6.151 billion euros in the same period last year. Of this, revenue from professional solutions was 3.08 billion euros (approximately 3.333 billion US dollars), compared to 3.026 billion euros in the same period last year. Revenue from consumer business was 3.255 billion euros, compared to 3.125 billion euros in the same period last year.

Alcon Announces First Quarter 2024 Financial Results.Quarterly net sales were $2.444 billion, compared to $2.333 billion in the same period last year. Quarterly net profit was $248 million, compared to $174 million in the same period last year.

Bausch+Lomb Reports First Quarter 2024 Results. Revenue for the quarter was $1.099 billion, compared to $931 million in the same period last year. Net loss attributable to the company for the quarter was $167 million, compared to a net loss of $90 million in the same period last year.

More exciting content

Welcome to follow WeChat Video Channel

Instrument Family

Related Reading

Tap for more!

"The Strongest Husband-and-Wife Team in the Medical Device Industry" Is Going Public Again

"King of Imaging in County Cities" Passes HKEX Hearing

2023 Medical Device Industry Salary Ranking: Mindray First

Just now, the Shenzhen Stock Exchange inquired about this medical device company

Hear Clearly, Stay Ahead: Cochlear Launches the All-in-One Sound Processor Kanso™ in China

Instrument Family: Top 10 Surgical Robot Innovations in 2024

The World's Largest Private Medical Device Manufacturer: Layoffs and Plant Closures

What's the Outcome? Philips Sues "Largest Third Party"

Average Annual Salary of $750,000: The Income Ranking of the U.S. Medical Device Industry is Here

Johnson & Johnson, Three Senior Executives Resign

BusinessBusiness cooperation email: qxzj@landianyiliao.com